Clinical Trials Browser

Phase 2 × Lymphoma, B-Cell × Cytarabine × Clear all

Burkitt Lymphoma, Hodgkin Disease, Lymphoma, Lymphoma, Follicular, Lymphoma, B-Cell

NCT02718755 2018-06-26

Phase II Study of Fludarabine, Cytarabine (ARA-C) and Erwinase IV in Patients With Relapsed or Refractory Hematologic Malignancies

Burkitt Lymphoma, Lymphoma, Recurrence, Leukemia, Biphenotypic, Acute, Leukemia, Prolymphocytic, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00577629 2017-05-30

Chemotherapy With Monoclonal Antibody and Radioimmunotherapy for High-Risk B-Cell Non-Hodgkins Lymphoma

Phase 2 Completed

39 enrolled 11 charts

Lymphoid

Lymphoma, B-Cell

NCT00210314 2015-03-30

Phase II Trial of Combined Modality Treatment in Primary Central Nervous System Lymphoma

Phase 2 Completed

79 enrolled

Lymphoid

Lymphoma, B-Cell

Clinical Trials

Autologous Transplant in HIV Patients (BMT CTN 0803)

Phase II Study of Fludarabine, Cytarabine (ARA-C) and Erwinase IV in Patients With Relapsed or Refractory Hematologic Malignancies

Chemotherapy With Monoclonal Antibody and Radioimmunotherapy for High-Risk B-Cell Non-Hodgkins Lymphoma

Phase II Trial of Combined Modality Treatment in Primary Central Nervous System Lymphoma